{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:11:17Z","timestamp":1791403877118,"version":"4.3.3"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR26970\/NNT\/28\/1509\/2017"],"award-info":[{"award-number":["BT\/PR26970\/NNT\/28\/1509\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019304","name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.carbpol.2022.120007","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:32:22Z","timestamp":1660822342000},"page":"120007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Oil-free eye drops containing Cyclosporine A\/cyclodextrin\/PVA supramolecular complex as a treatment modality for dry eye disease"],"prefix":"10.1016","volume":"297","author":[{"given":"Pinal","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Birangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha","family":"Mavlankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Sruthi","family":"Mallela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanhita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Kodoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavan","family":"Nampoothiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaila A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carbpol.2022.120007_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115287","article-title":"Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: In silico prediction; effects of derivatization, molar ratio and preparation method","volume":"227","author":"Adeoye","year":"2020","journal-title":"Carbohydrate Polymers"},{"issue":"6","key":"10.1016\/j.carbpol.2022.120007_bb0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.drudis.2016.04.002","article-title":"Modern approaches to the ocular delivery of cyclosporine a","volume":"21","author":"Agarwal","year":"2016","journal-title":"Drug Discovery Today"},{"issue":"7","key":"10.1016\/j.carbpol.2022.120007_bb0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jop.2016.0013","article-title":"Formulation and in vitro evaluation of cyclosporine-a inserts prepared using hydroxypropyl methylcellulose for treating dry eye disease","volume":"32","author":"Al-Saedi","year":"2016","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocular Surface"},{"key":"10.1016\/j.carbpol.2022.120007_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107829","article-title":"Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics","volume":"189","author":"Chaudhari","year":"2019","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.carbpol.2022.120007_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121409","article-title":"A supramolecular thermosensitive gel of ketoconazole for ocular applications: In silico, in vitro, and ex vivo studies","volume":"613","author":"Chaudhari","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.carbpol.2022.120007_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.carbpol.2015.08.012","article-title":"Inclusion complex of erlotinib with sulfobutyl ether-\u03b2-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation","volume":"134","author":"Devasari","year":"2015","journal-title":"Carbohydrate Polymers"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0050","first-page":"632","article-title":"A mouse model of Keratoconjunctivitis Sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.carbpol.2022.120007_bb0055","series-title":"Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease - Google Patents (Patent No. EP2923702A1)","author":"EP2923702A1","year":"2014"},{"issue":"4","key":"10.1016\/j.carbpol.2022.120007_bb0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/10807680260218524","article-title":"INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model","volume":"18","author":"Fujihara","year":"2002","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0065","first-page":"117","article-title":"Phase solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Advances in Analytical Chemistry and Instrumentation"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2022.120007_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2015.07.040","article-title":"Development of a cyclodextrin-based aqueous cyclosporin a eye drop formulations","volume":"493","author":"J\u00f3hannsd\u00f3ttir","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.molstruc.2016.09.025","article-title":"Inclusion complex of chrysin with sulfobutyl ether-\u03b2-cyclodextrin (Captisol\u00ae): Preparation, characterization, molecular modelling and in vitro anticancer activity","volume":"1128","author":"Kulkarni","year":"2017","journal-title":"Journal of Molecular Structure"},{"issue":"5","key":"10.1016\/j.carbpol.2022.120007_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: Biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.carbpol.2022.120007_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040285","article-title":"Enhanced dissolution and oral bioavailability of cyclosporine a: Microspheres based on \u03b1\u03b2-cyclodextrins polymers","volume":"10","author":"Lahiani-Skiba","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine a delivery to the eye: A pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"9","key":"10.1016\/j.carbpol.2022.120007_bb0100","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jps.10444","article-title":"Properties and stability of a liquid crystal form of cyclosporine - the first reported naturally occurring peptide that exists as a thermotropic liquid crystal","volume":"92","author":"Lechuga-Ballesteros","year":"2003","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0105","first-page":"1","article-title":"Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse","volume":"7","author":"Lee","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: Report of the definition and classification Subcommittee of the International dry eye Workshop (2007)","volume":"5","author":"Lemp","year":"2007","journal-title":"The Ocular Surface"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpharm.2017.04.049","article-title":"Effect of guest drug character encapsulated in the cavity and intermolecular spaces of \u03b3-cyclodextrins on the dissolution property of ternary \u03b3-cyclodextrin complex","volume":"531","author":"Liu","year":"2017","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"10.1016\/j.carbpol.2022.120007_bb0120","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","article-title":"Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage","volume":"13","author":"Liu","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2022.120007_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(97)00371-2","article-title":"The effect of water-soluble polymers on the aqueous solubility and complexing abilities of \u03b2-cyclodextrin","volume":"163","author":"Loftsson","year":"1998","journal-title":"International Journal of Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2022.120007_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1773-2247(04)50003-5","article-title":"The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs","volume":"14","author":"Loftsson","year":"2004","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.carbpol.2022.120007_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/OPTH.S126668","article-title":"Dry eye syndrome: Developments and lifitegrast in perspective","volume":"12","author":"Lollett","year":"2018","journal-title":"Clinical Ophthalmology"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","article-title":"Hen\u2019s egg chorioallantoic membrane test for irritation potential","volume":"23","author":"Luepke","year":"1985","journal-title":"Food and Chemical Toxicology"},{"issue":"5","key":"10.1016\/j.carbpol.2022.120007_bb0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.eye.6700169","article-title":"A randomised, crossover, multicentre study to compare the performance of 0.1% (w\/v) sodium hyaluronate with 1.4% (w\/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome","volume":"16","author":"McDonald","year":"2002","journal-title":"Eye"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2022.120007_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2005.12.013","article-title":"Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving","volume":"311","author":"Memisoglu-Bilensoy","year":"2006","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.carbpol.2022.120007_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/026520400417658","article-title":"Biodegrable nanoparticles as a delivery system for cyclosporine: Preparation and characterization","volume":"17","author":"Molpeceres","year":"2000","journal-title":"Journal of Microencapsulation"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/mp3005963","article-title":"Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability","volume":"10","author":"Morrison","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.colsurfb.2018.09.011","article-title":"Drug-in-mucoadhesive type film for ocular anti-inflammatory potential of amlodipine: Effect of sulphobutyl-ether-beta-cyclodextrin on permeation and molecular docking characterization","volume":"172","author":"Nanda","year":"2018","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.carbpol.2022.120007_bb0175","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.1988.01060130530029","article-title":"Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca","volume":"106","author":"Nelson","year":"1988","journal-title":"Archives of Ophthalmology (Chicago, Ill. : 1960)"},{"issue":"6","key":"10.1016\/j.carbpol.2022.120007_bb0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1755-3768.1977.tb05675.x","article-title":"Treatment of keratoconjunctivitis sicca with liquid paraffin or polyvinyl alcohol in double-blind trial","volume":"55","author":"Norn","year":"1977","journal-title":"Acta Ophthalmologica"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: An overview","volume":"2","author":"Patel","year":"2013","journal-title":"World Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2011.06.028","article-title":"Extended cyclosporine delivery by silicone-hydrogel contact lenses","volume":"154","author":"Peng","year":"2011","journal-title":"Journal of Controlled Release"},{"issue":"8","key":"10.1016\/j.carbpol.2022.120007_bb0195","first-page":"921","article-title":"Variant in the TNFRl gene associated with response to topical anti-TNF\u03b1 antibody fragment OCS-02 in patients with dry eye disease | IOVS | ARVO journals","volume":"62","author":"Perez","year":"2021","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.carbpol.2022.120007_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119552","article-title":"Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation","volume":"585","author":"Polat","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054245","article-title":"Non-apoptotic toxicity of Pseudomonas aeruginosa toward murine cells","volume":"8","author":"Roy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.carbpol.2022.120007_bb0210","series-title":"Polysaccharides: Bioactivity and biotechnology","first-page":"247","article-title":"Cyclodextrins","author":"S\u00e1 Couto","year":"2015"},{"issue":"8","key":"10.1016\/j.carbpol.2022.120007_bb0215","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1023\/A:1011956327987","article-title":"Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line","volume":"15","author":"Saarinen-Savolainen","year":"1998","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000310237","article-title":"Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis","volume":"203","author":"Sasamoto","year":"1991","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.carbpol.2022.120007_bb0225","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/pharmaceutics12090861","article-title":"Ex-vivo trans-corneal and trans-scleral diffusion studies with ocular formulations of glutathione as an antioxidant treatment for ocular diseases","volume":"12","author":"Sebasti\u00e1n-Morell\u00f3","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.carbpol.2022.120007_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2021.07.008","article-title":"Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis","volume":"167","author":"Shah","year":"2021","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"10","key":"10.1016\/j.carbpol.2022.120007_bb0235","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/ICO.0000000000002633","article-title":"A water-free 0.1% cyclosporine a solution for treatment of dry eye disease: Results of the randomized phase 2B\/3 ESSENCE study","volume":"40","author":"Sheppard","year":"2021","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.carbpol.2022.120007_bb0240","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/js960389h","article-title":"Influence of alpha-cyclodextrin and hydroxyalkylated \u03b2-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions","volume":"86","author":"Siefert","year":"1997","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2022.120007_bb0245","series-title":"Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics","first-page":"281","article-title":"Alternative technologies to improve solubility and stability of poorly water-soluble drugs","author":"da Silva J\u00fanior","year":"2017"},{"key":"10.1016\/j.carbpol.2022.120007_bb0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/5584_2019_348","article-title":"Variability of dry eye disease following removal of lacrimal glands in rats","volume":"1153","author":"Skrzypecki","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1\u20133","key":"10.1016\/j.carbpol.2022.120007_bb0255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.colsurfa.2010.04.040","article-title":"Low-bond axisymmetric drop shape analysis for surface tension and contact angle measurements of sessile drops","volume":"364","author":"Stalder","year":"2010","journal-title":"Colloids and Surfaces A: Physicochemical and Engineering Aspects"},{"issue":"3","key":"10.1016\/j.carbpol.2022.120007_bb0260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocular Surface"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.carbpol.2022.120007_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119396","article-title":"Sulfobutylether-\u03b2-cyclodextrin","volume":"583","author":"Stella","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"10.1016\/j.carbpol.2022.120007_bb0275","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jps.10445","article-title":"Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR","volume":"92","author":"Stevenson","year":"2003","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0280","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/acs.molpharmaceut.1c00746","article-title":"Voriconazole-cyclodextrin supramolecular ternary complex-loaded ocular films for management of fungal keratitis","volume":"19","author":"Suvarna","year":"2021","journal-title":"Molecular Pharmaceutics"},{"issue":"7","key":"10.1016\/j.carbpol.2022.120007_bb0285","first-page":"834","article-title":"The immunosuppressive effects of 0.025% cyclosporin eye drops in alpha cyclodextrin on rabbit corneal allografts","volume":"96","author":"Takano","year":"1992","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.carbpol.2022.120007_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020192","article-title":"Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a","volume":"13","author":"Terreni","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.carbpol.2022.120007_bb0295","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: Topical ophthalmic use of cyclosporin a","volume":"18","author":"Utine","year":"2010","journal-title":"Ocular Immunology and Inflammation"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2022.120007_bb0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5173(02)00664-6","article-title":"Effect of PVP K-25 on the formation of the naproxen:\u03b2-ciclodextrin complex","volume":"253","author":"Valero","year":"2003","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.carbpol.2022.120007_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03639040500388359","article-title":"Preparation of hydrophobic drugs cyclodextrin complex by lyophilization monophase solution","volume":"32","author":"Wang","year":"2006","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"4","key":"10.1016\/j.carbpol.2022.120007_bb0310","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The Core mechanism of dry eye disease (DED) is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye & Contact Lens"},{"issue":"4","key":"10.1016\/j.carbpol.2022.120007_bb0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsps.2014.11.009","article-title":"Characterization of new eye drops with choline salicylate and assessment of their irritancy by in vitro short time exposure tests","volume":"23","author":"Wroblewska","year":"2015","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"9","key":"10.1016\/j.carbpol.2022.120007_bb0320","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3109\/10717544.2016.1172368","article-title":"In vivo tissue distribution and efficacy studies for cyclosporin a loaded nano-decorated subconjunctival implants","volume":"23","author":"Yavuz","year":"2016","journal-title":"Drug Delivery"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861722009122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861722009122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:36:04Z","timestamp":1758933364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861722009122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":64,"alternative-id":["S0144861722009122"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2022.120007","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oil-free eye drops containing Cyclosporine A\/cyclodextrin\/PVA supramolecular complex as a treatment modality for dry eye disease","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2022.120007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120007"}}